Press "Enter" to skip to content

Opioid bills could net millions for companies

Positive Sentiment
Negative Sentiment
Content Analyzed

Those poised to benefit include:

 Alkermes, which spent $1 million lobbying in part to support a bill to fund full-service centers where people can detox, receive medical care and start treatment – a setup that could boost the fortunes of its best-selling product, anti-addiction treatment Vivitrol, which has been held back by the need for patients to fully detox before taking the drug. ”

Braeburn said the bill simply codifies prior understandings, and that it supports policies that open up access to all treatments for opioid use disorder.

Be First to Comment

Leave a Reply